Treatment response to erenumab in refractory migraine patients

被引：0
|
作者：
Messina, R.
Cetta, I.
Guerrieri, S.
Colombo, B.
Filippi, M.
机构：
[1] IRCCS San Raffaele Sci Inst, Neurol Unit, Milan, Italy
[2] Univ Vita Salute San Raffaele, Milan, Italy
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2020年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO2161
引用
收藏
页码：864 / 864
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of erenumab in migraine treatment
    Wang, Yongsheng
    Zhao, Han
    MINERVA SURGERY, 2024,
  • [32] Erenumab for the treatment of chronic resistant migraine
    Layos-Romero, Almudena
    Lopez, Alberto Andres
    Bartolome, Laura Rojas
    MEDICINA CLINICA, 2022, 158 (02): : 96 - 97
  • [33] Exposure-Response of Erenumab (AMG 334) in Episodic Migraine Patients
    Vu, Thuy
    Kuchimanchi, Mita
    Wu, Liviawati
    Clements, John D.
    Kahn, Joseph
    Mikol, Daniel
    Lee, Edward
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 : S81 - S81
  • [34] Treatment With OnabotulinumtoxinA vs Erenumab for Patients With Acquired/posttraumatic Chronic Migraine
    Rothrock, J. F.
    Tinsley, A.
    Koutsandreas, A. K.
    HEADACHE, 2020, 60 : 145 - 145
  • [35] Efficacy of erenumab for the treatment of patients with chronic migraine in presence of medication overuse
    Tepper, Stewart J.
    Diener, Hans-Christoph
    Ashina, Messoud
    Brandes, Jan L.
    Friedman, Deborah T.
    Reuter, Uwe
    Cheng, Sunfa
    Leonardi, Dean
    Lenz, Robert A.
    Mikol, Daniel D.
    CEPHALALGIA, 2017, 37 : 33 - 34
  • [36] Efficacy of erenumab for the treatment of patients with chronic migraine in presence of medication overuse
    Diener, H. -C.
    Ashina, M.
    Brandes, J.
    Friedman, D.
    Reuter, U.
    Tepper, S.
    Cheng, S.
    Leonardi, D.
    Lenz, R.
    Mikol, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 472 - 472
  • [37] Efficacy of Erenumab for the Treatment of Patients with Chronic Migraine in Presence of Medication Overuse
    Tepper, S. J.
    Diener, H.
    Ashina, M.
    Brandes, J. L.
    Friedman, D., I
    Reuter, U.
    Cheng, S.
    Leonardi, D. K.
    Lenz, R. A.
    Mikol, D. D.
    HEADACHE, 2017, 57 : 197 - 197
  • [38] Two Year Real World Prospective Quality of Life Data in Treatment Refractory Chronic Migraine Patients Treated with Erenumab in Ireland
    Troy, E.
    Shrukalla, A. A.
    Buture, A.
    Conaty, K.
    Macken, E.
    Lonergan, R.
    Melling, J.
    Long, N.
    Shaikh, E.
    Tomkins, E.
    Ruttledge, M.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 121 - 122
  • [39] Chronic migraine treatment with erenumab: Responder rates
    Diener, Hans-Christoph
    Brandes, Jan
    Dolezil, David
    Freeman, Marshall C.
    McAllister, Peter J.
    Winner, Paul
    Cheng, Sunfa
    Leonardi, Dean K.
    Lenz, Robert A.
    Mikol, Daniel D.
    JOURNAL OF HEADACHE AND PAIN, 2017, 18
  • [40] Chronic Migraine Treatment with Erenumab: Responder Rates
    Brandes, Jan L.
    Diener, Hans-Christoph
    Dolezil, David
    Freeman, Marshall C.
    Mcallister, Peter J.
    Winner, Paul
    Cheng, Sunfa
    Leonardi, Dean
    Lenz, Robert A.
    Mikol, Daniel D.
    CEPHALALGIA, 2017, 37 : 36 - 37
12345